Risk Factors for Severe Bleeding Complications in Glaucoma Surgery and the Role of Antiplatelet or Anticoagulant Agents.
Peer LauermannAnthea KlingelhöferDorothee MielkeDirk BahlmannHans HoeraufJuergen KoscielnyChristoph SuckerNicolas FeltgenChristian van OterendorpPublished in: Clinical ophthalmology (Auckland, N.Z.) (2022)
According to the results of our study cohort, glaucoma procedures entailing scleral manipulations (trabeculectomy and viscocanaloplasty) and concomitant diseases such as the history of a deep vein thrombosis or peripheral arterial occlusive disease influence the risk of severe intraoperative bleeding events, we detected no increased risk related to concomitant antiplatelet and/ or anticoagulant medication use.